Triple-negative breast cancer at SABCS 2026
Dec 8–11, 2026 San Antonio, TX ~11k attendees Website
4 organizations at SABCS 2026 present work in triple-negative breast cancer. 4 of them have their own page in this guide. As of Sep 27, 2026.
Showing 1–4 of 4 organizations
| Organization | SABCS 2026 Attendance |
|---|---|
AstraZeneca Cambridge, UK | |
Global drugmaker whose breast cancer medicines include HER2- and TROP2-directed antibody-drug conjugates and treatments for hormone receptor-positive disease. | Booth Exhibiting at Booth 624 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Gilead Sciences Foster City, CA | |
Biopharma company whose cancer portfolio spans antibody-drug conjugates, small molecules and, through Kite, cell therapies. | Booth Exhibiting at Booth 608 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Lantern Pharma Dallas, TX | |
Oncology drug developer using AI and genomics to speed discovery, with candidates for DNA-repair-deficient cancers including triple-negative breast cancer. | Booth Exhibiting at Booth 1153 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Merck & Co. Rahway, NJ | |
Global drugmaker with one of the largest oncology development programs, spanning more than 30 tumor types, including immunotherapy for triple-negative breast cancer. | Booth Exhibiting at Booth 1108 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Instantly find 20 buyers in triple-negative breast cancer
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse SABCS 2026 by
Organization type
Focus
- Patient and family support 26
- Genomic and tumor testing 22
- Hormone receptor-positive breast cancer 17
- Clinical trials and research 16
- HER2-positive breast cancer 10
- Liquid biopsy and MRD 10
- AI and data 9
- Screening and early detection 9
- Side effects and supportive care 8
- Breast surgery and biopsy 8
- Metastatic breast cancer 5
- Triple-negative breast cancer 4
- Hereditary risk and genetic testing 4
Exhibit hall
Everyone
Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published exhibitor list. Submit a correction